入排依据:The record is a Phase III randomized trial with a time-to-event endpoint (DFS) in human prostate cancer. However, the abstract is empty and the provided metadata (including the deterministic review's 'drug_intervention: false' signal) does not contain explicit evidence that a systemic drug intervention was part of the trial's control or experimental arms. The trial involves 'Androgen Deprivation' which could be a drug intervention (e.g., androgen antagonists), but this is not explicitly confirmed as a drug-containing intervention in the provided data. Therefore, eligibility cannot be confirmed.
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板